Skip to main content

Decoy Therapeutics Inc.

corporate_fare Company Profile

Decoy Therapeutics Inc.

DCOY·NASDAQ·Life Sciences·CIK 0001615219

Decoy Therapeutics Inc. is a pre-clinical stage biotechnology company focused on developing peptide conjugate therapeutics. The company utilizes its proprietary IMP 3 ACT™ platform, which incorporates machine learning ("ML") and artificial intelligence ("AI") tools with high-speed synthesis techniques. This platform is designed to engineer, optimize, and manufacture peptide conjugates to address unmet medical needs. Decoy Therapeutics aims to build a portfolio of these therapeutics, initially concentrating on infectious diseases and oncology. The company's goal is to become a fully integrated biopharmaceutical company in this field. Decoy Therapeutics has no products approved for commercial sales and has not generated any revenue from product sales. Prior to January 8, 2026, the company was known as Salarius Pharmaceuticals, Inc. ("Salarius"). In November 2025, Salarius completed a merger with Legacy Decoy and raised capital through financings. On January 8, 2026, Salarius changed its name to Decoy Therapeutics Inc.

Decoy Therapeutics Inc. (NASDAQ:DCOY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for DCOY at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Decoy Therapeutics Finalizes 1-for-12 Reverse Stock Split to Maintain Nasdaq Listing
  • Stockholders Approve Reverse Stock Split and New Equity Incentive Plan

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$12.52M
Diluted EPS
-$129.10
Op. Cash Flow
-$4.83M
Free Cash Flow
-$5.4M
Operating Income
-$12.61M
Cash & Equivalents
$10.71M
Debt / Equity
0.00×
Shares Outstanding
96.97K sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-195909
$0.845 +1.88% today
52-week range · as of 2026-11-13 $0.845 – $16.92
Market cap
$1.98M
Volume
38K (0.7× avg)
3-mo avg 56.5K
Live data · 2026-11-22 12:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DCOY - Filings & News (Page 2)

DCOY
Mar 05, 2026, 9:21 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.610
Real-time Price: $0.845 info
Change: Reverse Stock Split info
Market Cap: $1.978M info
DCOY
Feb 25, 2026, 9:15 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6813
Real-time Price: $0.845 info
Change: Reverse Stock Split info
Market Cap: $1.978M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets